Absolute 0 8 0 8 B-clinical_variable
Neutrophil 9 19 9 19 I-clinical_variable
Count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
< 32 33 32 33 O
1.5 33 36 33 36 B-upper_bound
x 37 38 37 38 I-upper_bound
109 39 42 39 42 I-upper_bound
/ 42 43 42 43 I-upper_bound
L 43 44 43 44 I-upper_bound

Aspartate 0 9 45 54 B-clinical_variable
aminotransferase 10 26 55 71 I-clinical_variable
( 27 28 72 73 I-clinical_variable
AST 28 31 73 76 I-clinical_variable
) 31 32 76 77 I-clinical_variable

Documented 0 10 78 88 O
progression 11 22 89 100 O
of 23 25 101 103 O
disease 26 33 104 111 O
according 34 43 112 121 O
to 44 46 122 124 O
RECIST 47 53 125 131 O
v1.1 54 58 132 136 O
following 59 68 137 146 O
primary 69 76 147 154 O
standard 77 85 155 163 O
of 86 88 164 166 O
care 89 93 167 171 O
( 94 95 172 173 O
e.g. 95 99 173 177 O
erlotinib 100 109 178 187 B-treatment
, 109 110 187 188 O
gefitinib 111 120 189 198 B-treatment
) 120 121 198 199 O

Documented 0 10 200 210 O
progression 11 22 211 222 O
of 23 25 223 225 O
disease 26 33 226 233 O
according 34 43 234 243 O
to 44 46 244 246 O
RECIST 47 53 247 253 O
v1.1 54 58 254 258 O
following 59 68 259 268 O
standard 69 77 269 277 O
of 78 80 278 280 O
care 81 85 281 285 O
( 86 87 286 287 O
e.g. 87 91 287 291 O
platinum 92 100 292 300 B-treatment
doublet 101 108 301 308 I-treatment
) 108 109 308 309 O

ECOG 0 4 310 314 B-clinical_variable
performance 5 16 315 326 I-clinical_variable
status 17 23 327 333 I-clinical_variable
â‰¤ 24 25 334 335 O
2 26 27 336 337 B-upper_bound

EGFR 0 4 338 342 B-cancer
T790 5 9 343 347 I-cancer
M 9 10 347 348 I-cancer
NSCLC 11 16 349 354 B-cancer
( 17 18 355 356 O
adenocarcinoma 18 32 356 370 B-cancer
) 32 33 370 371 O

EGFR 0 4 372 376 B-clinical_variable
wild 5 9 377 381 O
- 9 10 381 382 O
type 10 14 382 386 O
NSCLC 15 20 387 392 B-cancer

Hemoglobin 0 10 393 403 B-clinical_variable
( 11 12 404 405 I-clinical_variable
Hgb 12 15 405 408 I-clinical_variable
) 15 16 408 409 I-clinical_variable
< 17 18 410 411 O
9 18 19 411 412 B-upper_bound
g 20 21 413 414 I-upper_bound
/ 21 22 414 415 I-upper_bound
dL 22 24 415 417 I-upper_bound

History 0 7 418 425 O
of 8 10 426 428 O
allergy 11 18 429 436 O
or 19 21 437 439 O
hypersensitivity 22 38 440 456 O
to 39 41 457 459 O
nivolumab 42 51 460 469 B-allergy_name
components 52 62 470 480 I-allergy_name

Platelets 0 9 481 490 B-clinical_variable
< 10 11 491 492 O
100 11 14 492 495 B-upper_bound
x 15 16 496 497 I-upper_bound
109 17 20 498 501 I-upper_bound
/ 20 21 501 502 I-upper_bound
L 21 22 502 503 I-upper_bound

Previous 0 8 504 512 B-treatment
treatment 9 18 513 522 I-treatment
with 19 23 523 527 I-treatment
a 24 25 528 529 I-treatment
c 26 27 530 531 I-treatment
- 27 28 531 532 I-treatment
MET 28 31 532 535 I-treatment
inhibitor 32 41 536 545 I-treatment
or 42 44 546 548 I-treatment
HGF 45 48 549 552 I-treatment
- 48 49 552 553 I-treatment
targeting 49 58 553 562 I-treatment
therapy 59 66 563 570 I-treatment
( 67 68 571 572 O
applies 68 75 572 579 O
only 76 80 580 584 O
to 81 83 585 587 O
Group 84 89 588 593 O
2 90 91 594 595 O
) 91 92 595 596 O

Serum 0 5 597 602 B-clinical_variable
creatinine 6 16 603 613 I-clinical_variable
> 17 18 614 615 O
1.5 18 21 615 618 B-lower_bound
x 22 23 619 620 I-lower_bound
ULN 24 27 621 624 I-lower_bound

Serum 0 5 625 630 B-clinical_variable
lipase 6 12 631 637 I-clinical_variable
> 13 14 638 639 O
ULN 15 18 640 643 O

Total 0 5 644 649 B-clinical_variable
bilirubin 6 15 650 659 I-clinical_variable
> 16 17 660 661 O
1.5 17 20 661 664 B-lower_bound
x 21 22 665 666 I-lower_bound
upper 23 28 667 672 I-lower_bound
limit 29 34 673 678 I-lower_bound
of 35 37 679 681 I-lower_bound
normal 38 44 682 688 I-lower_bound
( 45 46 689 690 I-lower_bound
ULN 46 49 690 693 I-lower_bound
) 49 50 693 694 I-lower_bound

Tumor 0 5 695 700 B-cancer
tissue 6 12 701 707 I-cancer
for 13 16 708 711 O
determination 17 30 712 725 O
and/or 31 37 726 732 O
confirmation 38 50 733 745 O
of 51 53 746 748 O
genetic 54 61 749 756 O
pre 62 65 757 760 O
- 65 66 760 761 O
requisites 66 76 761 771 O
( 77 78 772 773 O
i.e. 78 82 773 777 O
EGFR 83 87 778 782 O
T790 88 92 783 787 O
M 92 93 787 788 O
positivity 94 104 789 799 O
post 105 109 800 804 O
progression 110 121 805 816 O
on 122 124 817 819 O
EGFR 125 129 820 824 B-clinical_variable
TKI 130 133 825 828 I-clinical_variable
for 134 137 829 832 O
Group 138 143 833 838 O
1 144 145 839 840 O
; 145 146 840 841 O
cMet 147 151 842 846 O
status 152 158 847 853 O
for 159 162 854 857 O
Group 163 168 858 863 O
2 169 170 864 865 O
) 170 171 865 866 O
must 172 176 867 871 O
be 177 179 872 874 O
provided 180 188 875 883 O
for 189 192 884 887 O
analysis 193 201 888 896 O

alanine 0 7 897 904 B-clinical_variable
aminotransferase 8 24 905 921 I-clinical_variable
( 25 26 922 923 I-clinical_variable
ALT 26 29 923 926 I-clinical_variable
) 29 30 926 927 I-clinical_variable
> 31 32 928 929 O
3 32 33 929 930 B-lower_bound
x 34 35 931 932 I-lower_bound
ULN 36 39 933 936 I-lower_bound

any 0 3 937 940 O
known 4 9 941 946 O
or 10 12 947 949 O
suspected 13 22 950 959 O
, 22 23 959 960 O
current 24 31 961 968 O
or 32 34 969 971 O
past 35 39 972 976 O
history 40 47 977 984 O
of 48 50 985 987 O
, 50 51 987 988 O
autoimmune 52 62 989 999 B-chronic_disease
disease 63 70 1000 1007 I-chronic_disease

asymptomatic 0 12 1008 1020 O
serum 13 18 1021 1026 O
amylase 19 26 1027 1034 O
> 27 28 1035 1036 O
CTCAE 29 34 1037 1042 B-clinical_variable
Grade 35 40 1043 1048 I-clinical_variable
2 41 42 1049 1050 I-clinical_variable
( 43 44 1051 1052 O
1.5 44 47 1052 1055 B-lower_bound
- 47 48 1055 1056 O
2.0 48 51 1056 1059 B-upper_bound
x 52 53 1060 1061 I-upper_bound
ULN 54 57 1062 1065 I-upper_bound
) 57 58 1065 1066 O

brain 0 5 1067 1072 B-chronic_disease
metastases 6 16 1073 1083 I-chronic_disease

child 0 5 1084 1089 O
bearing 6 13 1090 1097 O
potential 14 23 1098 1107 O
who 24 27 1108 1111 O
refuse 28 34 1112 1118 B-contraception_consent
or 35 37 1119 1121 I-contraception_consent
are 38 41 1122 1125 I-contraception_consent
not 42 45 1126 1129 I-contraception_consent
able 46 50 1130 1134 I-contraception_consent
to 51 53 1135 1137 I-contraception_consent
use 54 57 1138 1141 I-contraception_consent
a 58 59 1142 1143 I-contraception_consent
highly 60 66 1144 1150 I-contraception_consent
effective 67 76 1151 1160 I-contraception_consent
method 77 83 1161 1167 I-contraception_consent
of 84 86 1168 1170 I-contraception_consent
contraception 87 100 1171 1184 I-contraception_consent

condition 0 9 1185 1194 O
requiring 10 19 1195 1204 O
chronic 20 27 1205 1212 O
systemic 28 36 1213 1221 B-treatment
treatment 37 46 1222 1231 I-treatment
with 47 51 1232 1236 O
either 52 58 1237 1243 O
corticosteroids 59 74 1244 1259 B-treatment
( 74 75 1259 1260 O
> 75 76 1260 1261 O
10 77 79 1262 1264 B-lower_bound
mg 80 82 1265 1267 I-lower_bound
daily 83 88 1268 1273 I-lower_bound
prednisone 89 99 1274 1284 B-treatment
equivalent 100 110 1285 1295 O
) 110 111 1295 1296 O

have 0 4 1297 1301 O
been 5 9 1302 1306 O
treated 10 17 1307 1314 O
with 18 22 1315 1319 O
prior 23 28 1320 1325 B-treatment
PD-1 29 33 1326 1330 I-treatment
and 34 37 1331 1334 I-treatment
PD 38 40 1335 1337 I-treatment
- 40 41 1337 1338 I-treatment
L1 41 43 1338 1340 I-treatment
agents 44 50 1341 1347 I-treatment

histologically 0 14 1348 1362 O
documented 15 25 1363 1373 O
locally 26 33 1374 1381 O
advanced 34 42 1382 1390 O
, 42 43 1390 1391 O
recurrent 44 53 1392 1401 O
and/or 54 60 1402 1408 O
metastatic 61 71 1409 1419 B-cancer
NSCLC 72 77 1420 1425 I-cancer

history 0 7 1426 1433 O
of 8 10 1434 1436 O
testing 11 18 1437 1444 O
positive 19 27 1445 1453 O
for 28 31 1454 1457 O
human 32 37 1458 1463 B-chronic_disease
immunodeficiency 38 54 1464 1480 I-chronic_disease
virus 55 60 1481 1486 I-chronic_disease
( 61 62 1487 1488 I-chronic_disease
HIV 62 65 1488 1491 I-chronic_disease
) 65 66 1491 1492 I-chronic_disease
or 67 69 1493 1495 O
known 70 75 1496 1501 O
acquired 76 84 1502 1510 B-chronic_disease
immunodeficiency 85 101 1511 1527 I-chronic_disease
syndrome 102 110 1528 1536 I-chronic_disease
( 111 112 1537 1538 I-chronic_disease
AIDS 112 116 1538 1542 I-chronic_disease
) 116 117 1542 1543 I-chronic_disease

interstitial 0 12 1544 1556 B-chronic_disease
lung 13 17 1557 1561 I-chronic_disease
disease 18 25 1562 1569 I-chronic_disease
that 26 30 1570 1574 O
is 31 33 1575 1577 O
symptomatic 34 45 1578 1589 O
or 46 48 1590 1592 O
may 49 52 1593 1596 O
interfere 53 62 1597 1606 O
with 63 67 1607 1611 O
the 68 71 1612 1615 O
detection 72 81 1616 1625 O
or 82 84 1626 1628 O
management 85 95 1629 1639 O
of 96 98 1640 1642 O
suspected 99 108 1643 1652 O
drug 109 113 1653 1657 O
- 113 114 1657 1658 O
related 114 121 1658 1665 O
pulmonary 122 131 1666 1675 O
toxicity 132 140 1676 1684 O

measured 0 8 1685 1693 O
or 9 11 1694 1696 O
calculated 12 22 1697 1707 O
creatinine 23 33 1708 1718 B-clinical_variable
clearance 34 43 1719 1728 I-clinical_variable
< 44 45 1729 1730 O
75 45 47 1730 1732 B-upper_bound
% 47 48 1732 1733 I-upper_bound
LLN 49 52 1734 1737 I-upper_bound

other 0 5 1738 1743 O
immunosuppressive 6 23 1744 1761 B-treatment
medications 24 35 1762 1773 I-treatment
within 36 42 1774 1780 O
14 43 45 1781 1783 B-upper_bound
days 46 50 1784 1788 I-upper_bound
of 51 53 1789 1791 O
treatment 54 63 1792 1801 B-treatment
start 64 69 1802 1807 O

positive 0 8 1808 1816 O
test 9 13 1817 1821 O
for 14 17 1822 1825 O
hepatitis 18 27 1826 1835 B-chronic_disease
B 28 29 1836 1837 I-chronic_disease
virus 30 35 1838 1843 I-chronic_disease
or 36 38 1844 1846 O
hepatitis 39 48 1847 1856 B-chronic_disease
C 49 50 1857 1858 I-chronic_disease
virus 51 56 1859 1864 I-chronic_disease
indicating 57 67 1865 1875 O
acute 68 73 1876 1881 O
or 74 76 1882 1884 O
chronic 77 84 1885 1892 B-chronic_disease
infection 85 94 1893 1902 I-chronic_disease

pregnant 0 8 1903 1911 B-pregnancy

received 0 8 1912 1920 O
more 9 13 1921 1925 O
than 14 18 1926 1930 O
one 19 22 1931 1934 B-lower_bound
prior 23 28 1935 1940 O
line 29 33 1941 1945 O
of 34 36 1946 1948 O
EGFR 37 41 1949 1953 B-treatment
TKI 42 45 1954 1957 I-treatment
therapy1 46 54 1958 1966 I-treatment
( 55 56 1967 1968 O
applies 56 63 1968 1975 O
only 64 68 1976 1980 O
to 69 71 1981 1983 O
Group 72 77 1984 1989 O
1 78 79 1990 1991 O
) 79 80 1991 1992 O

require 0 7 1993 2000 O
emergent 8 16 2001 2009 O
use 17 20 2010 2013 O
of 21 23 2014 2016 O
systemic 24 32 2017 2025 B-treatment
steroids 33 41 2026 2034 I-treatment
, 41 42 2034 2035 O
chronic 43 50 2036 2043 O
use 51 54 2044 2047 O
of 55 57 2048 2050 O
prednisone 58 68 2051 2061 B-treatment
( 69 70 2062 2063 O
greater 70 77 2063 2070 O
than 78 82 2071 2075 O
10 83 85 2076 2078 B-lower_bound
mg 85 87 2078 2080 I-lower_bound
or 88 90 2081 2083 O
an 91 93 2084 2086 O
equivalent 94 104 2087 2097 O
steroid 105 112 2098 2105 O
dose 113 117 2106 2110 O
daily 118 123 2111 2116 O
) 123 124 2116 2117 O
or 125 127 2118 2120 O
emergent 128 136 2121 2129 B-treatment
surgery 137 144 2130 2137 I-treatment
and/or 145 151 2138 2144 O
radiotherapy 152 164 2145 2157 B-treatment

